Author(s):
Ana K. Faizah, Libriansyah, Dwi Endarti, Tri M. Andayani
Email(s):
trimurtia@ugm.ac.id
DOI:
10.52711/0974-360X.2025.00343 
Address:
Ana K. Faizah1,2, Libriansyah3, Dwi Endarti4, Tri M. Andayani5*
1Doctoral Graduate Program, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
2Faculty of Pharmacy Department, Universitas Hang Tuah, Surabaya, Indonesia.
3Department of Internal Medicine, Dr. Ramelan Central Naval Hospital, Surabaya Indonesia.
4Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
5Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 5,
Year - 2025
ABSTRACT:
Diabetic foot ulcers are often associated with amputation of the lower extremities. Hyperbaric oxygen therapy is considered an adjuvant to accelerate wound healing and reduce the number of amputations in diabetic foot ulcer patients. The systematic review aimed to confirm the effect of hyperbaric oxygen therapy as an adjunct therapy in diabetic foot ulcer patients. PUBMED, SCOPUS, and COCHRANE will be used as databases. Eligible articles include those that compare hyperbaric oxygen therapy with standard therapy in diabetic foot ulcer patients published until March 2024. The main outcomes measured include wound healing, incidence of amputation, side effects, mortality, and quality of life. Two reviewers independently screened, extracted data, and assessed the risk of bias for the included papers. The COCHRANE system and ROBINS-I were used to assess the quality of studies. The search yielded 953 results, of which 39 full-text articles were evaluated for relevance. Sixteen studies met the inclusion criteria. Thirteen studies were randomized controlled trials. There were significant differences in wound healing and major amputations, whereas there were no significant differences in minor amputations. Six studies reported side effects of barotrauma and two studies reported no side effects in patients. Hyperbaric oxygen therapy improves wound healing and major amputations compared to standard therapy. Further research is needed, especially regarding patient criteria and the number of hyperbaric oxygen therapy sessions to be able to determine which one gets the most effective.
Cite this article:
Ana K. Faizah, Libriansyah, Dwi Endarti, Tri M. Andayani. Systematic Review: Effectiveness, Safety, and Quality of life for Diabetic Foot Ulcer patients with Hyperbaric Oxygen Therapy. Research Journal of Pharmacy and Technology. 2025;18(5):2399-6. doi: 10.52711/0974-360X.2025.00343
Cite(Electronic):
Ana K. Faizah, Libriansyah, Dwi Endarti, Tri M. Andayani. Systematic Review: Effectiveness, Safety, and Quality of life for Diabetic Foot Ulcer patients with Hyperbaric Oxygen Therapy. Research Journal of Pharmacy and Technology. 2025;18(5):2399-6. doi: 10.52711/0974-360X.2025.00343 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-5-66
REFERENCES:
1. Mendes J. Neves J. Diabetic Foot Infections: Current Diagnosis and Treatment. The Journal of Diabetic Foot Complications. 2012; 4(2): 26-45.
2. Prasad J. Netam AK. Sahu MK. Satapathy T. Current Concepts in Clinical Based Management of Diabetic Foot Infections: A Review. Research Journal of Pharmacology and Pharmacodynamics. 2017; 9(3): 157–166. doi: 10.5958/2321-5836.2017.00027.1
3. Frykberg RG. Number eight in the service of diabetic foot ulcer healing. Diabetes Care. 2020; 43: 515–517. doi: 10.2337/dc20-0729.
4. Gong XB, Feng RH, Dong HM, Liu WH, Gu YN, Jiang XY, et al. Efficacy and Prognosis of Hyperbaric Oxygen as Adjuvant Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Meta-Analysis Study. Front Pediatr. 2022; 10: 707136. doi:10.3389/fped.2022.707136
5. Boulton AJM, Armstrong DG, Kirsner RS, Attinger CE, Lavery LA, Lipsky BA, et al. Diagnosis and management of diabetic foot complications. Diabetes. 2018; (2): 1–20. doi: 10.2337/db20182-1
6. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017; 376(24): 2367–75. doi: 10.1056/NEJMra1615439.
7. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, et al. Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Clinical Infectious Diseases. 2012: 54(12): e132–73. https://doi.org/10.1093/cid/cis346
8. Lipsky BA, Senneville É, Abbas ZG, Aragón‐Sánchez J, Diggle M, Embil JM, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metabolism Res. 2020 Mar [cited 2024 Jun 10]; 36(S1): e3280. Available from: https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3280
9. Skrepnek GH, Mills JL, Armstrong DG. A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. PLoS One. 2015; 10(8): e0134914. doi: 10.1371/journal.pone.0134914
10. Abbas HA, El-Sayed AES, Al-Kadi L, Gad IG. Diabetic foot infections in Zagazig University Hospital: bacterial etiology, antimicrobial resistance and biofilm formation. Research J Pharm and Tech. 2014; 7(7): 783–8.
11. Abbas HA. Diabetic Foot Infection. Research Journal of Pharmacy and Technology. 2015; 8(5): 575–9.
12. Dewangan V, Pandey H. Pathophysiology and Management of Diabetes: A Review. Research Journal of Pharmacology and Pharmacodynamics. 2017; 9(4): 219–22.
13. Sangeetha V, Nandhini PS, Saraswathy M, Sasmitha D, Senthilkumar T, Deepa R. Diabetic Foot Care: A study. Asian Journal of Nursing Education and Research. 2019; 9(3): 422–8. Available from: https://ajner.com/AbstractView.aspx?PID=2019-9-3-30
14. Shilpa S. Risk Status of Lower Extremity Arterial Disease (LEAD) among persons with Diabetes Mellitus. Int J of Advances in Nur Management. 2019; 7(1): 13–9. Available from: https://www.indianjournals.com/ijor.aspx?target=ijor:ijanm&volume=7&issue=1&article=004
15. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery. 2019; 58(1): S1-S109.e33. doi: 10.1016/j.jvs.2019.02.016.
16. Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020; 13(1): 16. doi: 10.1186/s13047-020-00383-2.
17. Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M, et al. An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds. Value Health. 2018; Jan; 21(1): 27–32. doi: 10.1016/j.jval.2017.07.007.
18. Barshes NR, Sigireddi M, Wrobel JS, Mahankali A, Robbins JM, Kougias P, et al. The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle. 2013; 4(10): 4. doi: 10.3402/dfa.v4i0.21847.
19. Maheshwari P, Pavithra D, Neethu TT, Shanmugarajan TS, Shanmugasundaram P. Study on Health Outcomes in Diabetic Patients - Association Between Diabetic Foot Ulcer and Psychological Distress. Research Journal of Pharmacy and Technology. 2017; 10(1): 44–8. doi: 10.5958/0974-360X.2017.00011.7
20. Geetha V, Shrimant K, Sahu C, Susila. Assess Quality of Life (QOL) and Glycemic Level among Type 2 Diabetic Patients in Global Hospital and Research Centre and its Units, Sirohi, Rajasthan. Asian J Nur Edu and Research. 2017; 7(4): 577–82. doi: 10.5958/2349-2996.2017.00112.4
21. Sajel S, Saranya P. Quality of Life in patients experiencing Diabetic Foot Ulcer: A cross sectional study in a Clinical Pharmacist’s Perspective. Research J Pharm and Tech. 2017; 10(1): 219–22. doi: 10.5958/0974-360X.2017.00046.4
22. Capo X. Hyperbaric Oxygen Therapy Reduces Oxidative Stress and Inflammation, and Increases Growth Factors Favouring the Healing Process of Diabetic Wounds - PMC. Int J Mol Sci. 2023; 24(8): 7040. doi: 10.3390/ijms24087040.
23. Sunkari VG, Lind F, Botusan IR, Kashif A, Liu ZJ, Ylä-Herttuala S, et al. Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice. Wound Repair Regen. 2015; 23(1):98–103. doi: 10.1111/wrr.12253.
24. Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019; 109: 440–7. doi:10.1016/j.biopha.2018.10.142.
25. Yildirim AO, Eryilmaz M, Kaldirim U, Eyi YE, Tuncer SK, Eroǧlu M, et al. Effectiveness of hyperbaric oxygen and ozone applications in tissue healing in generated soft tissue trauma model in rats: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi. 2014; 20(3): 167–75. doi: 10.5505/tjes.2014.09465
26. Sonia M. Hyperbaric Oxygen Therapy (HBOT): An Overview. International Journal of Advances in Nursing Management. 2021; 9(1): 99–101.
27. Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care. 1996; 19(12): 1338–43. doi: 10.2337/diacare.19.12.1338.
28. Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: A double-blind randomized-controlled trial. European Journal of Vascular and Endovascular Surgery. 2003; 25(6): 513–8. doi: 10.1053/ejvs.2002.1911.
29. Kessler L, Bilbault P, Ortéga F, Grasso C, Passemard R, Stephan D, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers a prospective randomized study. Diabetes Care. 2003; 26(8): 2378–82. doi: 10.2337/diacare.26.8.2378.
30. Ortega MA, Fraile-Martinez O, Garcia-Montero, et al. A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina (Kaunas). 2021; 57(9):864. doi: 10.3390/medicina57090864.
31. Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F. Effect of Hyperbaric Oxygen Therapy on Healing of Diabetic Foot Ulcers. Journal of Foot and Ankle Surgery. 2008; 47(6): 515–9. doi:10.1053/j.fas.2008.08.002.
32. Löndahl M. Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers. Medical Clinics of North America. 2013; 97(5): 957–80. doi: 10.1177/1534734613486154.
33. Khandelwal S, Chaudhary P, Poddar DD, Saxena N, Singh RAK, Biswal UC. Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clinics and practice. 2013; 3(1): e9–e9. doi: 10.4081/cp.2013.e9.
34. Fedorko L, Bowen JM, Jones W, Oreopoulos G, Goeree R, Hopkins RB, et al. Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Care. 2016; 39(3): 392–9. doi: 10.2337/dc15-2001.
35. Chen CY, Wu RW, Hsu MC, Hsieh CJ, Chou MC. Adjunctive Hyperbaric Oxygen Therapy for Healing of Chronic Diabetic Foot Ulcers: A Randomized Controlled Trial. J Wound Ostomy Continence Nurs. 2017; 44(6): 536–45. doi: 10.1097/WON.0000000000000374.
36. Santema KTB, Stoekenbroek RM, Koelemay MJW, Reekers JA, Van Dortmont LMC, Oomen A, et al. Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: Results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care. 2018; 41(1): 112–9. doi: 10.2337/dc17-0654.
37. Perren S. Hyperbaric Oxygen Therapy in Ischaemic Foot Ulcers in Type 2 Diabetes: A Clinical Trial. Open Cardiovasc Med J. 2018; 12: 80–5. doi:10.2174/1874192401812010080.
38. Salama SE, Eldeeb AE, Elbarbary AH, Abdelghany SE. Adjuvant Hyperbaric Oxygen Therapy Enhances Healing of Nonischemic Diabetic Foot Ulcers Compared With Standard Wound Care Alone. International Journal of Lower Extremity Wounds. 2019; 18(1): 75–80. doi: 10.1177/1534734619829939.
39. Kumar A, Shukla U, Prabhakar T, Srivastava D. Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers. Journal of Anaesthesiology Clinical Pharmacology. 2020; 36(2): 213–8. doi: 10.4103/joacp.JOACP_94_19.
40. Baroni G, Porro T, Faglia E, Pizzi G, Mastropasqua A, Oriani G, et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care. 1987; 10(1): 81–6. doi: 10.2337/diacare.10.1.81.
41. Ennis WJ, Huang ET, Gordon H. Impact of Hyperbaric Oxygen on More Advanced Wagner Grades 3 and 4 Diabetic Foot Ulcers: Matching Therapy to Specific Wound Conditions. Advances in Wound Care. 2018; 7(12): 397–407. doi: 10.1089/wound.2018.0855.
42. Fadol EM, Suliman HM, Osman B, Abdalla SA, Osman WJA, Mohamed EM, et al. Therapeutic outcomes evaluation of adjuvant hyperbaric oxygen therapy for non-healing diabetic foot ulcers among sudanese patients. Diabetes Metab Syndr. 2021; 15(4): 102173. doi: 10.1016/j.dsx.2021.06.010.
43. Sharma R, Sharma SK, Mudgal SK. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials. Sci rep. 2019; 11(1): 2189. doi: 10.1038/s41598-021-81886-1.
44. Brouwer RJ, Lalieu RC, Hoencamp R, van Hulst RA, Ubbink DT. A systematic review and meta-analysis of hyperbaric oxygen therapy for diabetic foot ulcers with arterial insufficiency. Journal of Vascular Surgery. 2020; 71(2): 682-692.e1. doi: 10.1016/j.jvs.2019.07.082.
45. Camporesi EM. Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014; 41(3): 253–7.
46. Stoekenbroek RM, Santema TB, Legemate DA, Ubbink DT, Van Den Brink A, Koelemay MJW. Hyperbaric oxygen for the treatment of diabetic foot ulcers: A systematic review. European Journal of Vascular and Endovascular Surgery. 2014; 47(6): 647–55. doi: 10.1016/j.ejvs.2014.03.005.
47. Zhao D, Luo S, Xu W, Hu J, Lin S, Wang N. Efficacy and Safety of Hyperbaric Oxygen Therapy Used in Patients With Diabetic Foot: A Meta-analysis of Randomized Clinical Trials. Clin Ther. 2017t; 39(10) :2088-2094.e2. doi: 10.1016/j.clinthera.2017.08.014.
48. O’Reilly D, Linden R, Fedorko L, Tarride JE, Jones WG, Bowen JM, et al. A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Trials. 2011; 7(12): 69. doi: 10.1186/1745-6215-12-69.
49. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015; 2015(6): CD004123. doi: 10.1002/14651858.CD004123.pub4.
50. Zhang Z, Zhang W, Xu Y, Liu D. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: An updated systematic review and meta-analysis. Asian Journal of Surgery. 2022; 45(1): 68–78. doi: 10.1016/j.asjsur.2021.07.047.
51. Golledge J, Singh TP. Systematic review and meta-analysis of clinical trials examining the effect of hyperbaric oxygen therapy in people with diabetes-related lower limb ulcers. Diabet Med. 2019; 36(7): 813–26. doi: 10.1111/dme.13975.
52. Fu Q, Duan R, Sun Y, Li Q. Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics. Redox Biology. 2022; 53: 102352. doi: 10.1016/j.redox.2022.102352.
53. Bhutani S, Vishwanath G. Hyperbaric oxygen and wound healing. Indian J Plast Surg. 2012; 45(2):316–24. doi: 10.4103/0970-0358.101309.
54. Capo X. Hyperbaric Oxygen Therapy Reduces Oxidative Stress and Inflammation, and Increases Growth Factors Favouring the Healing Process of Diabetic Wounds - PMC. Int J Mol Sci. 2023; 24(8):7040. doi: 10.3390/ijms24087040.